You are here

zavegepant

Royalty Pharma nabs $475M milestone from Pfizer upon migraine nasal spray OK

Endpoints

Thu, 03/16/23 - 09:46 am

Pfizer's Biohaven bet pays off again as migraine nasal spray wins approval

BioSpace

Fri, 03/10/23 - 11:32 am

Pfizer cites positive results on nasal spray migraine treatment

Medical Xpress

Thu, 02/16/23 - 08:09 pm

Pfizer and Biohaven close collaboration agreements

Pharmaceutical Business Review

Thu, 01/6/22 - 10:54 am

Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role

Fierce Biotech

Mon, 12/6/21 - 10:50 am

Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs

Yahoo/Reuters

Tue, 11/9/21 - 10:38 am